• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无创通气不耐受:特征、预测因素及结局

Noninvasive Ventilation Intolerance: Characteristics, Predictors, and Outcomes.

作者信息

Liu Jinhua, Duan Jun, Bai Linfu, Zhou Lintong

机构信息

Department of Respiratory Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Respir Care. 2016 Mar;61(3):277-84. doi: 10.4187/respcare.04220. Epub 2015 Dec 29.

DOI:10.4187/respcare.04220
PMID:26715769
Abstract

BACKGROUND

Noninvasive ventilation (NIV) intolerance is one reason for NIV failure. However, the characteristics, predictors, and outcomes of NIV intolerance are unclear.

METHODS

A prospective observational study was performed in the respiratory intensive care unit of a teaching hospital. Subjects with acute respiratory failure who used NIV were enrolled. Initially, continuous use of NIV was encouraged. However, if the subject could not tolerate NIV, it was used intermittently. NIV intolerance was defined as termination of NIV due to subject refusal to receive it because of discomfort, even after intermittent use was attempted.

RESULTS

A total of 961 subjects were enrolled in the study. Of these, 50 subjects (5.2%) experienced NIV intolerance after a median 2.4 h of NIV support. Age (OR = 0.98, 95% CI 0.963-0.996) and heart rate (OR = 1.02, 95% CI 1.006-1.030) measured before NIV were 2 independent risk factors of NIV intolerance. After 1-2 h of NIV, independent risk factors of NIV intolerance were heart rate (OR = 1.03, 95% CI 1.016-1.044) and breathing frequency (OR = 1.06, 95% CI 1.027-1.099). Intolerant subjects had no improvement in mean arterial pressure, heart rate, or breathing frequency after the NIV intervention. Moreover, intolerant subjects had a higher intubation rate (44.0% vs 25.8%, P = .008) and higher mortality (34.0% vs 22.4%, P = .08). The three most common complaints were that NIV worsened subjects' distress (46%), that NIV resulted in dyspnea (26%), and that the flow or pressure of NIV was too strong to bear (16%).

CONCLUSIONS

NIV intolerance worsened subjects' outcomes. Younger subjects with a high heart rate and breathing frequency may be more likely to experience NIV intolerance.

摘要

背景

无创通气(NIV)不耐受是NIV失败的原因之一。然而,NIV不耐受的特征、预测因素和结果尚不清楚。

方法

在一家教学医院的呼吸重症监护病房进行了一项前瞻性观察研究。纳入使用NIV的急性呼吸衰竭患者。最初,鼓励持续使用NIV。然而,如果患者不能耐受NIV,则间歇使用。NIV不耐受定义为即使尝试间歇使用后,患者仍因不适拒绝接受NIV而导致NIV终止。

结果

共961名患者纳入研究。其中,50名患者(5.2%)在接受NIV支持中位数2.4小时后出现NIV不耐受。NIV前测量的年龄(OR = 0.98,95%CI 0.963 - 0.996)和心率(OR = 1.02,95%CI 1.006 - 1.030)是NIV不耐受的2个独立危险因素。NIV 1 - 2小时后,NIV不耐受的独立危险因素是心率(OR = 1.03,95%CI 1.016 - 1.044)和呼吸频率(OR = 1.06,95%CI 1.027 - 1.099)。不耐受的患者在NIV干预后平均动脉压、心率或呼吸频率无改善。此外,不耐受的患者插管率更高(44.0%对25.8%,P = 0.008),死亡率更高(34.0%对22.4%,P = 0.08)。最常见的三个主诉是NIV加重了患者的痛苦(46%)、NIV导致呼吸困难(26%)以及NIV的流量或压力过大难以忍受(16%)。

结论

NIV不耐受会使患者的预后恶化。心率和呼吸频率较高的年轻患者可能更易出现NIV不耐受。

相似文献

1
Noninvasive Ventilation Intolerance: Characteristics, Predictors, and Outcomes.无创通气不耐受:特征、预测因素及结局
Respir Care. 2016 Mar;61(3):277-84. doi: 10.4187/respcare.04220. Epub 2015 Dec 29.
2
Noninvasive ventilation for acute hypercapnic respiratory failure: intubation rate in an experienced unit.无创通气治疗急性高碳酸血症性呼吸衰竭:经验丰富的单位中的插管率。
Respir Care. 2013 Dec;58(12):2045-52. doi: 10.4187/respcare.02456. Epub 2013 Jun 4.
3
Early non-invasive ventilation treatment for respiratory failure due to severe community-acquired pneumonia.早期无创通气治疗重症社区获得性肺炎所致呼吸衰竭
Clin Respir J. 2016 Jan;10(1):98-103. doi: 10.1111/crj.12184. Epub 2014 Jul 28.
4
Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study.高流量鼻导管给氧与无创通气序贯应用于急性呼吸衰竭的观察性初步研究。
Respir Care. 2015 Feb;60(2):170-8. doi: 10.4187/respcare.03075. Epub 2014 Oct 7.
5
Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者发生急性呼吸衰竭时的无创通气
J Crit Care. 2014 Aug;29(4):562-7. doi: 10.1016/j.jcrc.2014.03.019. Epub 2014 Mar 30.
6
Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery: A Randomized Clinical Trial.腹部手术后低氧性呼吸衰竭患者接受无创通气对气管再插管的影响:一项随机临床试验。
JAMA. 2016 Apr 5;315(13):1345-53. doi: 10.1001/jama.2016.2706.
7
Outcomes of noninvasive ventilation in acute hypoxemic respiratory failure in a respiratory intensive care unit in north India.在印度北部的一家呼吸重症监护病房中,无创通气治疗急性低氧性呼吸衰竭的结果。
Respir Care. 2009 Dec;54(12):1679-87.
8
High-Flow Nasal Cannula Therapy Versus Intermittent Noninvasive Ventilation in Obese Subjects After Cardiothoracic Surgery.心胸外科手术后肥胖患者的高流量鼻导管吸氧疗法与间歇性无创通气比较
Respir Care. 2017 Sep;62(9):1193-1202. doi: 10.4187/respcare.05473. Epub 2017 Aug 14.
9
Predictors of outcome of noninvasive ventilation in severe COPD exacerbation.无创通气治疗重度 COPD 加重的结局预测因素。
BMC Pulm Med. 2019 Jul 18;19(1):131. doi: 10.1186/s12890-019-0892-9.
10
Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients.评估心率、酸中毒、意识、氧合和呼吸频率,以预测低氧血症患者无创通气失败。
Intensive Care Med. 2017 Feb;43(2):192-199. doi: 10.1007/s00134-016-4601-3. Epub 2016 Nov 3.

引用本文的文献

1
Low versus high positive end expiratory pressure in noninvasive ventilation for hypoxemic respiratory failure: a multicenter randomized controlled trial.低呼气末正压与高呼气末正压用于低氧血症性呼吸衰竭无创通气的多中心随机对照试验
Intensive Care Med. 2025 Apr 30. doi: 10.1007/s00134-025-07902-4.
2
High-velocity nasal insufflation versus noninvasive positive pressure ventilation for moderate acute exacerbation of chronic obstructive pulmonary disease in the emergency department: A randomized clinical trial.急诊科中高速经鼻吹气与无创正压通气治疗慢性阻塞性肺疾病中度急性加重的随机临床试验
Acad Emerg Med. 2025 Apr;32(4):403-413. doi: 10.1111/acem.15038. Epub 2024 Dec 11.
3
Noninvasive Positive Pressure Ventilation versus High-Flow Nasal Cannula for Chronic Obstructive Pulmonary Disease: An Updated Narrative Review.
无创正压通气与高流量鼻导管在慢性阻塞性肺疾病中的应用:更新的叙述性综述。
Int J Chron Obstruct Pulmon Dis. 2024 Nov 9;19:2415-2420. doi: 10.2147/COPD.S487994. eCollection 2024.
4
Qualitative study of COVID-19 patient experiences with non-invasive ventilation and pronation: strategies to enhance treatment adherence.COVID-19 患者无创通气和翻身经验的定性研究:提高治疗依从性的策略。
BMJ Open. 2023 Dec 9;13(12):e077417. doi: 10.1136/bmjopen-2023-077417.
5
High flow nasal oxygen as a "second-line" therapy for COVID-19 patients intolerant to noninvasive ventilation. A retrospective cohort study.高流量鼻导管给氧作为对无创通气不耐受的COVID-19患者的“二线”治疗。一项回顾性队列研究。
Health Sci Rep. 2023 Nov 15;6(11):e1685. doi: 10.1002/hsr2.1685. eCollection 2023 Nov.
6
High-Flow Nasal Oxygen versus Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Randomized Controlled Trials.高流量鼻氧疗与无创通气在慢性阻塞性肺疾病急性加重患者中的应用:随机对照试验的荟萃分析。
Can Respir J. 2023 Jun 30;2023:7707010. doi: 10.1155/2023/7707010. eCollection 2023.
7
Prediction of noninvasive ventilation failure using the ROX index in patients with de novo acute respiratory failure.使用ROX指数预测初发性急性呼吸衰竭患者无创通气失败情况。
Ann Intensive Care. 2022 Dec 5;12(1):110. doi: 10.1186/s13613-022-01085-7.
8
Transnasal High-Flow Oxygen Therapy versus Noninvasive Positive Pressure Ventilation in the Treatment of COPD with Type II Respiratory Failure: A Meta-Analysis.经鼻高流量氧疗与无创正压通气治疗 COPD 合并 II 型呼吸衰竭的疗效比较:一项 Meta 分析。
Comput Math Methods Med. 2022 Jul 26;2022:3835545. doi: 10.1155/2022/3835545. eCollection 2022.
9
Comfort During Non-invasive Ventilation.无创通气期间的舒适度。
Front Med (Lausanne). 2022 Mar 24;9:874250. doi: 10.3389/fmed.2022.874250. eCollection 2022.
10
Exploring the Patient Experience with Noninvasive Ventilation: A Human-Centered Design Analysis to Inform Planning for Better Tolerance.探索无创通气患者体验:以用户为中心的设计分析以指导提高耐受性的规划。
Chronic Obstr Pulm Dis. 2022 Jan 27;9(1):80-94. doi: 10.15326/jcopdf.2021.0274.